Neolpharma

active

Founded more than 31 years ago, Grupo Neolpharma (the “Company”) is a Mexico-based, family-owned, pharmaceutical company focused on the development, manufacture, distribution and sale of branded and unbranded generic medicines.  Through its related companies, Neolpharma has presence in Mexico, Puerto Rico, Peru and Ecuador.  It exports from Mexico to Colombia, El Salvador, Panama, Costa Rica, Guatemala, Honduras and the Dominican Republic.Neolpharma owns an active pharmaceutical ingredients (“API”) production plant, four pharmaceutical finished formulations production plants; one USFDA/EMA approved plant in Puerto Rico; two distribution companies; and a pharmacy chain in Mexico with 47 branches.  It is one of the leading domestic pharmaceutical companies in Mexico, primarily focused on prescription generics, with a portfolio of over 250 products in therapeutic areas such as central nervous system, cardiovascular, oncology and diabetes.  As of today, it employs approximately 2,485 full-time employees of which 49% are women.The proposed IFC’s financing aims to support Grupo Neolpharma’s expansion plan in Mexico, which includes ramping up production capabilities and climate related projects (the “Project”).